Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens

NCT00610792 · clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
91
Enrollment
INDUSTRY
Sponsor class

Stopped Study never submitted to IND. Study is being sponsored by Johnson and Johnson in the EU only.

Conditions

Interventions

Sponsor

Millennium Pharmaceuticals, Inc.